Pediatric Rheumatology Symposium

CE

In support of improving patient care, the American College of Rheumatology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Provider Number: 0003797

See the ACR’s CE Mission Statement. For more information, download the AMA PRA Booklet.

Participants should claim only the credit commensurate with the extent of their participation in the activity.

Credits must be claimed by (to be announced).

MOC

MOC Recognition Statement: American Board of Internal Medicine (ABIM)

Successful completion of this CE activity, which includes participation in the evaluation component, enables the participant to earn up to (to be announced) MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CE activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board.

After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.

MOC Recognition Statement: American Board of Pediatrics (ABP)

Successful completion of this CE activity, which includes participation in the evaluation component, enables the learner to earn up to (to be announced) MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CE activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABP diplomates to the ABP diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABP Physician Portfolio. Please allow at least 48 hours for points to display in the portfolio.

MOC points must be claimed by (to be announced).

Complete CE & MOC information to be announced.

See 2026 CE & MOC information in the 2026 meeting section below.

Instructions to Claim CE/MOC Credit

Credit claiming is available after the activity starts.

See instructions to claim credit on the CE & MOC page.

Complete CE & MOC information to be announced.

See 2026 CE & MOC information in the 2026 meeting section below.

ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Education (CE) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CE activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CE activity.

Nature of Financial Relationships
All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:

1. Advisor or review panel member
2. Consultant
3. Employee
4. Officer or Board Member
5. Grant/research support
6. Speaker/honoraria includes speakers bureau, symposia, and expert witness
7. Independent contractor
8. Executive role and/or ownership interest
9. Royalties and/or patient beneficiary
10. Intellectual property/patents
11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan
12. Private investigator
13. Expert witness
14. Equity interest
15. Other: specify details

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.

Pediatric Rheumatology Symposium Financial Relationships Disclosures to be announced.

View ACR's ACCME disclosure practices

See 2026 disclosures in the 2026 meeting section below.

The Pediatric Rheumatology Symposium 2026 was held in person from March 18–21 in Minneapolis, Minnesota.

The Pediatric Rheumatology Symposium (PRSYM) provides up-to-date, practical clinical information and basic science knowledge on the diagnosis and management of pediatric patients with rheumatic diseases and immune disorders.

Target Audience
Rheumatologists, physicians and other healthcare providers who care for pediatric patients with rheumatic diseases, clinical investigators, physician-scientists and those interested or engaged in research in the field of pediatric rheumatic diseases.

Learning Objectives
Upon completion of this activity, participants should be able to:

• Discuss the most up-to-date clinical information on the diagnosis and management of pediatric patients with rheumatic and immunologic disorders
• Describe the most current information regarding the pathophysiology underlying pediatric rheumatic disorders

Program Schedule & Syllabi

Pediatric Rheumatology Symposium Program Schedule

Abstracts

View the accepted Pediatric Rheumatology Symposium 2026 abstracts >

CE & MOC Information

CE

In support of improving patient care, the American College of Rheumatology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Provider Number: 0003797

See the ACR’s CE Mission Statement. For more information, download the AMA PRA Booklet.

Participants should claim only the credit commensurate with the extent of their participation in the activity.

Credits must be claimed by March 18, 2027, at 11:59 PM ET.

To claim credit, go to the activity page in the ACR Education Center.

CME Designation Statement

The ACR designates this Other/Blended Learning activity for a maximum of 18.25 AMA PRA Category 1 Credit(s)™.

ANCC Designation Statement

The American College of Rheumatology designates this Other/Blended Virtual Learning activity for a maximum of 18.25 ANCC contact hours.

MOC

MOC Recognition Statement: American Board of Internal Medicine (ABIM)

Successful completion of this CE activity, which includes participation in the evaluation component, enables the participant to earn up to 18.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CE activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board.

After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.

MOC Recognition Statement: American Board of Pediatrics (ABP)

Successful completion of this CE activity, which includes participation in the evaluation component, enables the learner to earn up to 18.25 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CE activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABP diplomates to the ABP diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABP Physician Portfolio. Please allow at least 48 hours for points to display in the portfolio.

MOC points must be claimed by March 18, 2027, at 11:59 PM ET.

Instructions to Claim CE/MOC Credit

Credit claiming is available after the activity starts.

See instructions to claim credit on the CE & MOC page.

Financial Relationships Disclosures

ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Education (CE) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CE activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CE activity.

Nature of Financial Relationships
All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:

1. Advisor or review panel member
2. Consultant
3. Employee
4. Officer or Board Member
5. Grant/research support
6. Speaker/honoraria includes speakers bureau, symposia, and expert witness
7. Independent contractor
8. Executive role and/or ownership interest
9. Royalties and/or patient beneficiary
10. Intellectual property/patents
11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan
12. Private investigator
13. Expert witness
14. Equity interest
15. Other: specify details

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.

PRSYM 2026 Financial Relationships Disclosures >

View ACR's ACCME disclosure practices

Acknowledgement of Commercial Support

No commercial support was provided for this activity.